Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 23,281 shares, a growth of 157.9% from the July 15th total of 9,026 shares. Based on an average daily volume of 69,598 shares, the days-to-cover ratio is currently 0.3 days.
Ono Pharmaceutical Stock Performance
Shares of OTCMKTS:OPHLY opened at $5.00 on Friday. The business has a 50 day moving average of $4.86 and a 200-day moving average of $5.03. Ono Pharmaceutical has a 12-month low of $3.55 and a 12-month high of $5.75.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty?pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co?developing and commercializing nivolumab (Opdivo), an anti–PD?1 immune checkpoint inhibitor developed in partnership with Bristol?Myers Squibb.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
